Paul Hamilton
Nessuna posizione attualmente
Storia della carriera di Paul Hamilton
Precedenti posizioni note di Paul Hamilton
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Karo Bio USA, Inc.
 Karo Bio USA, Inc. Miscellaneous Commercial ServicesCommercial Services Karo Bio USA, Inc. develops drug discovery technologies. It develops screening assays and drugs that work upon nuclear receptors. The company is headquartered in Chapel Hill, NC. | Direttore Tecnico/Scientifico/R&S | 01/01/2000 | 01/01/2004 |
| BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | - | - |
Affinergy LLC
 Affinergy LLC BiotechnologyHealth Technology Affinergy LLC develops site-specific biological systems using biofriendly linkers that selectively adhere to proteins, drugs, cells, and biomaterial surfaces. The firm focuses on developing coatings and medical devices for the orthopedic and cardiovascular markets. It constructs bifunctional peptide linkers that selectively immobilize proteins, cells, and therapeutics onto biomaterial surfaces. The firm offers its products for orthopedics, cardiovascular, and tissue engineering; and drug delivery and stem cells markets. The company was founded by Daniel J. Kenan, Jonathan Gindes, and Mark W. Grinstaff in 2002 and is headquartered in Durham, NC. | Direttore Tecnico/Scientifico/R&S | - | - |
Formazione di Paul Hamilton
| The Ohio State University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 3 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BECTON, DICKINSON AND COMPANY | Health Technology |
| Aziende private | 2 |
|---|---|
Affinergy LLC
Affinergy LLC BiotechnologyHealth Technology Affinergy LLC develops site-specific biological systems using biofriendly linkers that selectively adhere to proteins, drugs, cells, and biomaterial surfaces. The firm focuses on developing coatings and medical devices for the orthopedic and cardiovascular markets. It constructs bifunctional peptide linkers that selectively immobilize proteins, cells, and therapeutics onto biomaterial surfaces. The firm offers its products for orthopedics, cardiovascular, and tissue engineering; and drug delivery and stem cells markets. The company was founded by Daniel J. Kenan, Jonathan Gindes, and Mark W. Grinstaff in 2002 and is headquartered in Durham, NC. | Health Technology |
Karo Bio USA, Inc.
Karo Bio USA, Inc. Miscellaneous Commercial ServicesCommercial Services Karo Bio USA, Inc. develops drug discovery technologies. It develops screening assays and drugs that work upon nuclear receptors. The company is headquartered in Chapel Hill, NC. | Commercial Services |
- Borsa valori
- Insiders
- Paul Hamilton
- Esperienza